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Antimicrobial resistance challenges our ability to treat infections. Traditional approaches that rely on the inhibi-
tion of intracellular processes or cell wall synthesis with antibiotics of microbial origin contribute to the increasing 
number of resistant microorganisms1. Newly discovered, but similar compounds are subject to the same barriers 
of low-cost resistance mechanisms, impermeable membranes, dormant and persistent infections1–3. Alternative 
therapies require modes of action that lack such shortcomings4, and are consistent with the increasing use of 
membrane-active antibiotics such as polymyxins5. Host defense peptides (HDPs) are promising candidates6. hey 
constitute a major part of cell-free immunity and are evolutionarily conserved. herefore, developing widespread 
resistance against them is a formidable challenge for bacteria7. HDPs are typically cationic, readily engage with 
intracellular targets and favor attack on negatively charged microbial membranes of both growing and dormant 
bacteria, which renders them multi-target and hence generic antimicrobials8,9. In membranes the peptides fold as 
amphipathic α-helices or β-sheets that assemble into carpet-like structures, transmembrane pores or monolayer 
pits. Diferent modes of action manifest in diferent killing kinetics and may link to the phenotypic speciicity of 
HDPs to bacteria10. Strikingly, HDP sequences are very diverse6–10. Apart from cationic and hydrophobic residues 
that are common for HDPs, amino-acid residues and motifs that are not typical for all HDPs can be incorpo-
rated to provide distinct functions. For example, terminal tryptophans are oten used to anchor to membranes, 
and arginines are preferred over lysines for tighter electrostatic interactions in the upper lealet of the bilayer11. 
Helix-disrupting glycine zipper motifs, G(X)nG, where X is any residue and n = 3–6, help control transmembrane 
peptide oligomerisation and specify phosphate binding as a function of responsive folding12,13. All these features 
deine the shape of the folded structure, i.e. straight or kinked helix, its orientation relative to the membrane 
normal, i.e. parallel, perpendicular or tilted, and eventually the rate and extent of pore or carpet formation14–18.
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Implicit correlations for membrane-disrupting mechanisms have been demonstrated for unrelated sequences. 
Biological activities of peptides from the same family are also compared, but do not necessarily expose distinc-
tive membrane-disruption patterns for diferent family members or sequence mutants. We reason here that an 
HDP sequence is an intrinsic probe that encodes for diferent and tailorable modes of membrane disruption. 
Our rationale accepts membrane disruption as the primary cause of cell death6–9, which, consequently, puts an 
emphasis on two main factors:
Firstly, microbial membranes are phospholipid bilayers with a relatively universal thickness of 3–4 nm19–21. 
Gram negative bacteria comprise two bilayers, inner and outer, which are separated by a thin and porous 
peptidoglycan layer of 4 nm22. Following peptide attack on the outer membrane, the layer facilitates HDPs, 
to which it has high ainity, to reach the cytoplasmic membrane23. Gram positive membranes have only one 
membrane that is decorated with a thicker peptidoglycan, which may induce peptides to fold before they reach 
the phospholipid bilayer24. HDPs do not necessarily diferentiate between Gram positive and Gram negative 
membranes, but their activity may appear variable due to the phenotypic tolerance of bacterial cells and their 
inherent ability to oligomerize10,25. Most HDPs are relatively short sequences, <25 amino-acid residues, whereas 
longer HDPs, <50 residues, tend to incorporate glycine zipper motifs or glycine and proline residues to regulate 
membrane-responsive folding25–28.
Secondly, shorter peptides can form conformations capable of fully inserting into microbial bilayers. An 
amino-acid residue in a β-strand and an α-helix would span 0.3 nm and 0.15 nm, respectively, which allows 
for comparably strong antimicrobial sequences of 11–21 residues in length. Longer HDPs can incorporate 
sub-domains to anchor to membranes, adjust to membrane curvature, thin and micellise the membranes or 
intercalate in the bilayer at an angle bending the bilayer pores into toroidal structures29–31. Synthetic sequences 
composed of only cationic and hydrophobic residues can be hemolytic and fold in solution via interfacing hydro-
phobic faces32. his is also common for naturally occurring HDPs including human cathelicidins whose activity 
varies due to their tendency to form helical bundles that propagate into ilament-like structures33 or highly hemo-
lytic melittins that self-regulate pore formation34. Efective HDPs balance cationic and hydrophobic faces to an 
extent ensuring a selective binding to microbial membranes. his is in contrast to cytotoxic venom or neurotoxin 
peptides (e.g. melittin, pardaxin) that fail to diferentiate between zwitterionic mammalian and anionic microbial 
lipids, which obviates their use as antibiotics35,36.
Together these factors suggest that the length and composition of a given sequence act in an interplay that dis-
criminates and enables diferent modes of membrane disruption. Since HDPs from one family have little sequence 
similarity to other families, each family is likely to have evolved independently26,36. herefore, we explore here 
the impact of such an interplay on varying membrane disruption mechanisms using sequence alterations in an 
archetypal HDP. Such a peptide would span >3 nm in a folded state, comprise specialist residues or motifs with 
an apparent separation into sub-domains and exhibit a preferential membrane-disruption mechanism. We have 
identiied Cecropin B (CecB) as an ideal candidate to meet the above requirements and test our hypothesis by 
considering carefully chosen modiications of the peptide as shown in Fig. 1 and discussed in more detail below.

CecB, originally isolated from the cecropia moth Hyalophora cecropia, belongs to a super-family of α-helical 
HDPs36. It comprises 35 amino-acid residues that arrange into classical heptad repeats allowing for the forma-
tion of an amphipathic helix spanning ~5.25 nm (0.54 nm per turn)37. he irst (i) and the last (i + 7) residues in 
each heptad tend to be of the same type (i.e. polar or hydrophobic) (Fig. 1a and Table S1). In the folded helix, 
the residues are adjacent when viewed along its main helix, thus allowing the residues to segregate into opposite 
polar and hydrophobic faces. Resulting amphipathic helices orient more parallel to the surface of anionic micro-
bial membranes disrupting their phospholipid bilayers via a detergent-like carpet mechanism (Fig. 1c)27,38. CecB 
has three abutting and overlapping G(X)nG motifs that stretch from the second heptad of the N-terminus. his 
suggests that the irst 12 residues are primarily responsible for the helix formation and antimicrobial activity, 
which is also consistent with the importance of the N-terminal tryptophan (W2) for the activity (Fig. 1a,b)27. he 
contiguous stretch of the three glycine zippers subdivides the sequence into three sub-domains of comparable 
lengths (Fig. 1a). his structure compromises autonomous helix formation in solution and helps the helix to 
adapt to membrane curvature8. As the peptide reaches a threshold concentration membrane curvature increases, 
but without necessarily leading to poration16. he primary role of insertion is therefore to stretch, disorder and 
thin the outer lealet of the bilayer38, which proves suicient for detergent-like mechanisms15. hese assume a 
surface-bound state for peptide helices without a subsequent transmembrane insertion18. Instead, carpet-forming 
peptides intercalate below the glycerol backbone of the head groups forcing the expansion and thinning of the 
outer lealet8,39. Poration for these peptides, as a result of transmembrane insertion, is deemed unnecessary and 
diicult to accommodate. For instance, the length of CecB helices (5 nm) exceeds the thickness of the bilayer 
(<4 nm) imposing an implicit bias towards a non-poration mechanism (Fig. 1c)38.
Ǥ With these mech-
anistic models in mind, we monitored the impact of CecB on reconstituted phospholipid membranes using lipid 
compositions that produce luid-phase bilayers at biologically relevant temperatures21,40. Anionic unilamellar 
vesicles (AUVs) and zwitterionic unilamellar vesicles (ZUVs) provided microbial and mammalian membrane 
mimetics, respectively. 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) was used to assemble ZUVs, whereas 
its 3:1 molar mixture with 1,2-dilauroyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DLPG) was used to assemble 
AUVs20,25. As gauged by Circular dichroism (CD) spectroscopy, in AUVs CecB folded into a strong α-helix at 
micromolar chain concentrations, whereas no appreciable structure was found in aqueous bufers and ZUVs 
(Fig. S1a).
www.nature.com/scientificreports/
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To visualize directly the impact of CecB folding on the membranes, supported lipid bilayers (SLBs) were 
prepared by the surface deposition of the AUVs on appropriate substrates as previously described21. Such prepa-
rations are homogeneously lat, to within ~0.1 nm in their unperturbed state, and ofer ideal substrates for accu-
rate depth measurements by atomic force microscopy (AFM) in aqueous solution and in real time (Fig. S2)25,40. 
AFM analyses of SLBs incubated with CecB revealed corrugated surfaces without apparent poration over 90 min, 
suggesting that CecB denatures the bilayer in a non-cooperative manner (Figs 2 and S3)38. his mechanism is 
consistent with the primary structure of the peptide (Figs 1 and 2a).
Firstly, the C-terminal domain of CecB is preceded by a well-deined AGPA motif, the so-called hinge moiety, 
which bends the helix at an obtuse angle inducing signiicant lexibility in the region41. his enables the domain 
to fold independently of the N-terminal domains and act as an adaptable anchor lying lat on the membrane 
surface15,18. he domain incorporates small alanyl residues and is net neutral (Fig. 1a), which ensures weaker 
membrane binding. his is in stark contrast to hydrophobic and cationic residues, which have strong ainity to 
anionic membranes and appear exclusively in the N-terminal domains (Fig. 1a).
Secondly, the two N-terminal domains are continuously cationic, while the second (middle) domain features 
arginine residues straight ater the irst glycine residue (Fig. 1a). Arginines provide tighter and more extensive 
electrostatic interactions with anionic phospholipids when compared to lysines42. herefore, their incorporation 
into the irst glycine zipper, which generally weakens helicity, is to partially recover it by strengthening electro-
static interactions. Such helix-tuning supports membrane-mediated folding.
hirdly, the peptide is believed to form small channels at concentrations that are lower than minimum inhibi-
tory concentrations (MICs)43. hough such channels have yet to be observed, we reason that CecB has an intrinsic 
propensity for pore formation. We further reason that this propensity can be enhanced by (i) discarding the irst 
and the last glycyl residues in the sequence, thus retaining only the middle glycine zipper, and (ii) reshaping the 
i, i + 7 heptad pattern into i, i + 3 and i, i + 4 spacing pattern21. he latter is common for α-helical coiled coils 
and arranges cationic residues in a continuous seam exposed to oppositely charged moieties and hydrophobic 
residues in another seam promoting hydrophobic interfaces44. As a result, cooperative inter-helical interactions 
are enabled in anionic amphipathic environments, such as anionic membranes, leading to locally oligomerized 
helices. he resulting sequence is a two-domain structure, termed cecropin mutant or CecM (Fig. 1a). he peptide 
has one uninterrupted N-terminal domain whose length matches the bilayer thickness, allowing it to fully insert 
into the bilayer. Yet, the remaining glycine zipper in conjunction with the C-terminal domain hinged on the 
membrane surface by the AGPA motif can be expected to arrest transmembrane poration or prevent it altogether 
(Fig. 2a).
Figure 1. Cecropin sequence probes. Peptide sequences, linear (a) and conigured on helical wheels (b). 
Blue and grey cylinders denote helical N-terminal (blue) and C-terminal (grey) domains. Lysines are in blue, 
arginines and neutral polar residues are in light blue, relative identities of hydrophobic residues are in yellow. 
Glycine residues are in red and glycine zippers are highlighted by overarching horizontal brown brackets. 
Glycine residues in ChoC and their replacements in ChoM are in orange in the helical wheels. Green lines in the 
helical wheels of ChoC and ChoM indicate polar angles. he AGPA hinge and the W2 residue are underlined. 
A coiled-coil designation, gabcdef, is shown along the CecM sequence. Heptad repeats are shown underneath. 
Only two i, i + 7 pairs are given for clarity. (c) A schematic representation of a carpet-like mechanism by CecB 
oriented lat on a phospholipid bilayer. For clarity, only one phospholipid per lealet is shown (aliphatic chains 
in grey, headgroups in pink).
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ǦǤ Consistent with these conventions, CecM folded in 
AUVs, but not in aqueous bufers or ZUVs (Fig. S1b). As expected for helical assemblies and coiled-coils, spectral 
∆ε222/∆ε208 ratios were ≥145. In comparison, the ratios of <1 for CecB suggest that monomeric helical conform-
ers were predominant for the parent peptide (Fig. S1a). Unlike CecB, CecM formed abundant pores of 9 ± 2 nm 
diameter and ~1.5 nm in depth over the irst 10 min of incubation in SLBs (Figs 2b and S3). A priori, these obser-
vations and in particular the observed pore depths are consistent with monolayer poration25. However, given the 
small size and (V) shape of the pores, it cannot be excluded that the AFM tips used to measure the pores were 
not sharp enough to probe the full penetration depth in these experiments. Notwithstanding, the pores appeared 
remarkably homogeneous suggesting that poration is arrested laterally and possibly vertically. To gain a better 
insight into this process, the dynamics and modes of insertion for both peptides were assessed using molecular 
dynamics (MD) simulations. Diferent initial conigurations with respect to the membrane surface were used 
including lat, transmembrane or tilted (Fig. S4). Regardless of the conigurations, the behaviours of the two 
peptides were drastically diferent. Over the half microsecond time scales, CecB formed rod-like helices that ori-
ented parallel to the membrane surface. he helices intercalated below the head groups of the outer lealet, which 
largely explains the preference for carpet-like mechanisms (Fig. 3a and Movie S1). CecM helices, on the other 
hand, rapidly adopted a kinked conformation that assumed tilted orientations with the N-terminus of the peptide 
sinking deep into the bilayer interface (Fig. 3a and Movie S2). Simulations showed a greater helical content for 
CecM when compared to CecB (Table S2 and Fig. S5). At no point during the simulation did the peptide adopt 
Figure 2. Membrane disruption mechanisms in DLPC/DLPG (3:1, molar ratio) supported lipid bilayers.  
(a) Schematic representations of relative orientations of cecropin peptides in lipid bilayers: (from top down) 
CecB, CecM, Choc and ChoM. Designations are as in Fig. 1. (b) Topography of SLBs treated with cecropin 
peptides (let) and cross-sections along the highlighted lines (right). he images were taken at 90 min (CecB), 
15 min (CecM), 10 min (ChoC) and 6 min (ChoM) of incubation. Color scale is 6 nm.
www.nature.com/scientificreports/
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a transmembrane orientation (Movies S1 and S2). Instead, it tended to cluster phospholipids into oligomeric 
structures, in accord with observations by others for other HDPs14,46. Combined with the experimental evidence, 
the MD results indicate the preference of CecM to form ixed pores of relatively small sizes as a characteristic 
signature.
The findings also re-emphasise the role of the C-domain as a topological constraint of poration, which 
may regulate pore sizes and penetration depths. herefore, truncating CecB at the start of the AGPA motif was 
expected to remove such a constraint prompting more aggressive and heterogeneous poration. Indeed, the 
N-terminal part of CecB, dubbed chopped cecropin (ChoC), formed larger pores of varied sizes, allowing to 
conidently measure the pore depths of ~2.7 nm, which conformed to ChoC spanning the hydrophobic core of 
the bilayer (Figs 2 and S3). he full length of the peptide (~3.2 nm) matches the thickness of the bilayer, allowing 
for the complete insertion of the peptide in the membrane (Fig. 2a). In addition, MD simulations conirmed that 
ChoC helices immediately adopted a transmembrane coniguration, which remained stable over the half micro-
second simulation following an equilibration phase (Fig. 3a and Movie S3). ChoC exhibited appreciable helicity in 
AUVs, with spectral characteristics (∆ε222/∆ε208 < 1) typical of monomeric helices (Fig. S1c). As outlined above, 
the arginyl residues within the retained glycine zipper may regain or strengthen helix formation, which also sug-
gests that breaking helicity is not the main function of the zipper. More likely, the motif is meant to discriminate 
against inter-helical associations in favor of monomeric helices, given it takes at least three abutting heptads to 
interdigitate an α-helix47. ChoC matches the length, but falls short of three contiguous heptads because of the 
zipper. he same holds true for CecB, whereas the N-terminal domain of CecM stretches nearly three heptads 
to the only interruption by the irst glycyl residue (Fig. 1a). Note should be taken however that only high resolu-
tion structural elucidations may reveal the exact nature of the conformational changes observed in the sequence 
mutants.
ǦǤ A modiied sequence, dubbed ChoM, was produced to replace 
the two glycines with isoleucyl and lysyl residues, giving rise to an uninterrupted helix with a similar polar angle 
(Fig. 1b). CD spectra conirmed the responsive folding of the peptide with an apparent tendency for inter-helical 
associations in AUVs (∆ε222/∆ε208 > 1), resembling that of CecM (Fig. S1b,d). Unlike CecM, ChoM is free of 
a-priori constraints for membrane binding and insertion and lacks an apparent coiled-coil pattern that could 
otherwise aid in restricting oligomerisation in the membrane48.
Figure 3. Peptide orientations in membranes. (a) 0.5 µs snapshots of molecular dynamics simulations for 
individual cecropin peptides in AUVs. (b) A representative simulation for ChoM following an equilibration 
phase (0 ns). Key: peptide helices are in magenda, lipid aliphatic chains are in cyan, phospholipid headgroups 
are green spheres (see also Movies S1–S4).
www.nature.com/scientificreports/
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As a consequence, ChoM cannot arrest pore formation and is promiscuous in lipid binding (Fig. 1a). his is 
further compounded by that arginines are no longer conined within a helix breaker and can form cooperative 
electrostatic networks on the membrane surfaces, which may endow the peptide with substantial freedom of 
lateral movement without the need to insert and orient in the membranes25. Indeed, MD simulations showed 
cooperative interactions between arginines and anionic phospholipids for ChoM, which were greater in num-
bers when compared to the other three peptides (Fig. S6). As judged by AFM, the peptide did not assemble 
into pores or corrugated SLBs as CecB does. Instead, it exfoliated the bilayers within the irst ten minutes of 
incubation (Figs 2b and S3). he measured depth proiles were consistent with the progressive removal of the 
outer lealet of the bilayer. Comparable results of monolayer poration were obtained for thicker SLBs (~4 nm), 
which were assembled as 3:1 molar mixtures of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 
1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (POPG) lipids (Fig. S7). he efect 
was distinct from that of CecB which corrugated the SLBs in the same manner observed for the DL-type mem-
branes (Figs 2, S3 and S7). hese thicker bilayers contain unsaturated lipids, which alone cannot support an ori-
entational order and their thicknesses exceed the span of the folded ChoM. he saturated lipids of DLPC/DLPG 
bilayers are more densely packed and their thickness (3.2 nm) can match the complete transmembrane span of 
the folded ChoM. However, irrespective of these diferences, ChoM promoted the same poration mechanism in 
both membrane types. he observed efect may also suggest that more precise variations in poration in diferent 
lipid types may not be fully ascertained in supported lipid bilayers. he results are yet consistent with that HDPs 
are universal membrane disrupters that lyse microbial cells, not necessarily speciically, but rapidly within the 
time limits of their proteolytic stability6–9,18. Complementary to folding characteristics in DL-type bilayers, CD 
spectra for CecM and ChoM in the thicker membranes were distinctive from those for ChoC and CecB (Fig. S8).
he exfoliation process was reminiscent of phenomena observed in outer lealets exposed to prion proteins or 
bacterial cassette transporters49,50, although in these cases monolayer pits, as opposed to monolayer exfoliation, 
occur. Another analogy can be found in monolayer stalks formed by amphiphysin N-BAR domains during mem-
brane fusion51. Of more direct relevance, however, is a mechanistic model, which proposes that HDPs act by splaying 
phospholipids of the outer lealet8. his mode of action does not make a particular reference to poration and places 
a stronger emphasis on the thinning of bacterial membranes as a means of membrane rupture. It also assumes an 
oblique orientation of peptide helices with respect to the membrane surface. Previously, we have shown that such an 
orientation can lead to rapid antimicrobial mechanisms targeting the outer lealet of the bilayer25. However, mem-
brane exfoliation ensued via monolayer poration, which was not observed for ChoM. Non-poration exfoliation is 
intriguing because it does not fall under either category of pore or carpet formation. According to MD simulations, 
ChoM has a clear preference to intercalate under the phospholipid headgroups of the outer layer without attempting 
to span the membranes (Fig. 3a and Movie S4). Similar to CecM the peptide tended to arrange into higher oligomers 
in contrast to ChoC and CecB, which showed preference for monomeric and dimeric forms (Fig. S9). he simula-
tions also revealed that the ChoM helices were only marginally tilted with respect to the membrane surface (Fig. 3b), 
and that on average they appeared as more rigid and less curved than ChoC, thus introducing local conformational 
changes fostering interactions of arginine residues in membranes (Fig. S10).
Together with the rapid exfoliation observed by AFM, these results imply that ChoM helices are held in the 
headgroup layer by strong electrostatic interactions causing a large degree of disruption. Indeed, as demonstrated 
by solid state 2H NMR (ssNMR) spectra obtained in AUVs assembled from phospholipids with deuterated acyl 
chains, there was signiicant disorder in both lipid components, suggesting an in-planar peptide orientation 
(Fig. S11)52. At decreasing lipid-to-peptide (L/P) ratios (increasing peptide), ChoM induced clear segmental 
ordering in lipids, with reduced 2H quadrupolar splittings indicating a more pronounced membrane disruption 
upon binding more peptide (Fig. S11, Table S3). A larger disrupting efect is observed for the anionic lipid compo-
nent suggesting a charge-driven interaction. he results are consistent with the peptide intercalating in the inter-
face region of the bilayer and suggest a synergistic and charge-driven mode of action causing membrane thinning, 
estimated from the observed order changes to be 3.6 Å and 5.5 Å for the neutral and anionic components, respec-
tively52. To complement the data, angular constraints informing the orientation of the peptide with respect to 
the bilayer normal were obtained using the geometric analysis of labelled alanines (GALA) by oriented ssNMR 
spectroscopy (Figs 4, S12). Four ChoM peptides, each being the ChoM sequence mutated at a single position with 
a deuterated alanine (Ala-d3) (Table S4). All selectively deuterated residues were resolved in large quadrupolar 
splittings indicating a non-transmembrane orientation (Figs 4a, S12). A minor second component was apparent 
for the C-terminal half of the peptide, which is suggestive of more heterogeneous orientation or partial fraying of 
ChoM helices in the region (Table S5, the distinct populations are interchanging slowly: >10−6 s). At lower L/P 
ratios (increased peptide concentration) an increased distortion of lipid bilayers was expected as a larger propor-
tion of lipids would interact with peptide (Fig. S12). Since bilayer disordering is typically more pronounced for 
peptides splaying the upper lealet than for transmembrane peptides52, the efect could be attributed to that the 
peptide remained in the bilayer in its designed anchored position.
he itting of the individual deuterium constraints to root-mean-square deviation plots returned an over-
all orientation for all of the four mutants as nearly parallel to the membrane surface, within a marginal tilt of 
2° +/− 8° for the ensemble (based on a maximum RMSD of 10 kHz for an error estimate, Fig. S13). Based on these 
results, it can be concluded that ChoM intercalates and assembles close to the hydrophobic interface in the bilayer 
brushing through the interface and irreversibly perturbing the bilayer with membrane exfoliation as a result. In 
terms of biological activity, we hypothesize that this mechanism should favour a faster attack on bacteria, man-
ifesting in faster killing rates when compared to those for the other three cecropin peptides as described below.
Ǥ Consistent with the above results and discussion, live/dead assays 
revealed a nearly complete lysis of E. coli and B. subtilis cells by the irst 15 min of exposure to ChoM, with no 
cells surviving within the irst cell doubling (20 min) (Fig. S14). he data closely correlated with the exfoliation 
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rates observed by AFM. Similarly, ChoC that exhibited pore formation developing over an hour in reconstituted 
membranes tended to reach quantitative killing rates just ater the irst hour of incubations. CecM proved to have 
comparable rates with those of ChoC suggesting that the diferences in pore sizes and morphology caused by the 
two peptides have little or no efect on killing kinetics (Fig. S15). he analysis of membrane disruption by CecB 
was complicated by the absence of clearly recognisable features in the disrupted reconstituted membranes (Figs 2 
and S3). his hampered a mechanistic interpretation of its killing kinetics. Nevertheless, the peptide showed 
comparable killing rates with those for CecM and ChoC (Figs S14 and S15).
In native hosts, HDPs are secreted to tackle opportunistic pathogens within minutes, their proteolytic life 
time. herefore, the observed rates, both in reconstituted and live membranes, indicate that the disruption mech-
anisms of this cecropin series become apparent within the timescale of native biological responses. he live-dead 
assays provide accurate estimations of antimicrobial action at the level of individual cells. However, the tests are 
devoid of contributions from other factors such as the phenotypic tolerance of bacteria to antibiotics and inocu-
lum efects32. Optical density measurements performed for the bulk of bacterial culture over much longer periods 
of time give more generic estimations of biological activity. Expressed as MICs the results of these measurements 
refer to the lowest concentrations of tested agents at which bacteria show no visible growth. All four peptides 
were found to have MICs in the low range that is typical of potent antimicrobial agents (Table 1). CecB showed 
distinctively lower activities against B. subtilis, which is somewhat surprising given that killing kinetics of the 
peptide were similar to those of ChoC and CecM in the irst hour of treatment (Fig. S14). his indicates that the 
peptide failed to afect bacterial growth over longer incubations, suggesting that such incubations may be more 
profoundly subject to inoculum efects or peptide depletion during the process. Similarly, all GALA peptides, 
which constitute a short alanine scan of the sequence, maintained antimicrobial activities at comparable levels, 
with the exception of S. aureus (Table S6). he GALA peptides were less active against the bacterium. Partly, 
this can be explained by that the alanine scan reduced the overall hydrophobicity of each peptide, having also 
an efect on binding ainities of peptide molecules to membranes. However, with no signiicant variations in 
activity against the other bacteria tested, the exact nature of this efect is unclear. It may be attributed to that local 
conformational changes in GALA peptides may be more prone to the partial folding and pre-oligomerisation of 
the peptides in thicker peptidoglycans on the surface of S. aureus leading to the inhibition of peptide migration 
to the cytoplasmic membrane53.
CecB and ChoC were also virtually inactive against S. aureus, though lower activities against Gram positive 
strains did not appear systematic. By comparison, daptomycin – a membrane-active antibiotic that preferen-
tially porates Gram positive membranes – selectively inhibited Gram positive bacteria. Intracellular antibiot-
ics, tetracycline and cetriaxone, were equally efective against all bacteria tested, demonstrating expected broad 
Figure 4. ChoM orientation in AUVs. (a) Oriented 2H NMR quadrupolar splittings in AUVs (POPC/POPG, 
3:1 molar ratio) at L/P ratio 25 for four ChoM mutants each with a single deuterated alanine (Ala-d3) mutation 
at positions 4, 8, 12 and 20, respectively. (b) A GALA-derived helix model showing relative positions of labelled 
Ala-d3 (brown).
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spectrum activities. Amongst the four cecropin peptides, only ChoM gave notably low MICs against all strains 
used (Table 1), suggesting a distinctive antimicrobial mechanism.
Non-diferential antimicrobial responses relect the nature of HDPs as non-speciic agents that rapidly kill 
pathogens on contact. In many cases this carries an additional cost of hemolytic efects given the weakly anionic 
surfaces of erythrocytes32. In the studied series, except daptomycin that was weakly hemolytic, hemolysis was not 
apparent (Table 1 and S6). Daptomycin is a net negative molecule, but decisively hydrophobic, which makes it 
more related to host defense toxins exhibiting extensive hydrophobic faces. However, it does not target Gram neg-
ative bacteria, against which the cecropin peptides were potent. HDPs bind to lipid bilayers as monomers, which 
then assemble into pores or carpet-like structures. hese form continuously and lead to the progressive disruption 
of lipid bilayers. Such mechanisms have been observed in both lipid bilayers and live bacteria21,25, and the times-
cales of these physical events are consistent with the rapid lysis of bacterial cells. Complementary to non-speciic 
binding to bacterial membrane bilayers, the peptides can also bind to lipopolysaccharides (LPS) of Gram nega-
tive cell walls and their precursors, which have been proposed as primary targets for HDPs54. Variations in the 
activities against Gram negative strains did take place in the cecropin series, with ChoC being noticeably weaker 
against a Gram negative S. typhimurium.
ǦǤ To explore these variations, the peptides 
were tested against cross-resistant strains of S. typhimurium, which were experimentally derived from the wild 
type bacterium subjected to increasing concentrations of pore-forming human HDPs55. hree genetic mutations 
were selected as candidate contributors to resistance and were reconstituted in the wild type genetic background, 
giving rise to the strains given in Table 2. One strain has the waaY gene mutated. his gene encodes for WaaY 
kinase that adds a phosphate group to the heptose II residue in the LPS inner core. he deactivation of the gene 
leads to decreased susceptibility to HDPs56, as a result of reducing peptide binding to cell surfaces to the levels 
below those necessary to lyse the bacterium57. Two other strains were mutated in pmrB and phoP genes, both 
of which are involved in masking phosphate groups (diminished charge) and inluencing membrane luidity 
(restricted motion)58. Finally, the fourth strain combined all three mutations (Table 2).
Antimicrobial activities measured against these strains revealed two major trends. Corresponding MICs for 
the cecropin peptides were doubled when compared to those against the wild type bacterium. Although the 
strains appeared as more resistant, overall the MICs remained low, with the exception of ChoC, for which the 
two-fold decrease essentially meant the loss of activity (Table 2). Although this could be for a variety of reasons, 
cell
Compound
daptomycin tetracycline cetriaxone CecB CecM ChoC ChoM
Minimum inhibitory concentrations, µM
P. aeruginosa >100 <6 >25 <1.5 <1.5 <1.5 <1.5
S. aureus <7 <0.5 <3 >100 >25 >100 <3
E. coli >100 <1.5 <6 <1 <1.5 <6 <3
B. subtilis <7 <0.5 <1 >50 <7 <5 <1.5
S. typhimurium >60 <1 <1 <3 <1 >12 <3
M. luteus <15 <0.5 <0.5 <1 <1 <1 <0.5
(LC50)a, µM
HEb >250c UD UD >250d >250d >250d >250d
Table 1. Biological activities of antibiotics and peptides used in the study. aMedian (50%) lethal concentration. 
bHuman erythrocytes. c10% hemolysis. d<1% hemolysis. UD is for undetectable (>1000).
Compound
Mutanta
DA6192
DA22427 waaY 
(del bp17FS)
DA23175 
pmrB (R13H)
DA23307 
phoP (D23N)
DA23899 waaY, 
pmrB, phoP
Minimum inhibitory concentrations, µM
polymyxin B <0.5 <0.5 <0.5 <2 <6
amhelin20 >6 >25 >12 >12 >50
tilamin24 >3 >6 >25 >12 >50
CecB <3 <3 <3 <3 >6
CecM <1 <1 <1 <2 <2
ChoC >12 >12 >25 >25 >25
ChoM <3 <6 <6 <6 <6
tetracycline <1 <1 <1 <1 <1
cetriaxone <1 <1 <1 <1 <1
Table 2. Cross resistance of S. typhimurium to antimicrobial agents used in the study. aOriginal nomenclature is 
used55.
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this efect did not seem to relate to the waaY mutation, but did to the other two mutations, albeit without a dom-
inant impact from one or another. Because ChoC was the only peptide in the series that formed transmembrane 
pores, one may expect that poration could be more susceptible to such basic alterations in membranes. Indeed, 
the two pore-forming synthetic peptides that were as active against the wild type of S. typhimurium as were the 
cecropin peptides, were found inactive against the strain combining all three mutations (Table 2). A similar trend 
of weakened activity was observed for polymyxin B – an endotoxin-binding antibiotic which depolarises Gram 
negative membranes by forming ion-permeable pores. However, transmembrane poration by the antibiotic does 
not seem to be a primary cause of bacterial death59. Polymyxin B is known to aggregate with LPS on the surfaces 
of S. typhimurium cells forming the so-called blebs in the outer lealet of the bacterium membrane60. he process 
is not exactly associated with membrane exfoliation or monolayer poration, but does require acidic phospholip-
ids to increase membrane permeability61. ChoM, which does not form visible pores but disrupts the outer lealet 
of bacterial membranes, shared the same level of activity against the resistant strain. In this light, CecM, which 
formed pores and gave the lowest MICs against all four strains, may only disrupt outer lealets with small pits 
that are nonetheless suicient to kill the bacteria. he results also conirm that the activity of membrane-active 
antibiotics and HDPs depends on the eiciency with which they target bacterial membranes. Synergistic and 
more profound efects by HDPs concern the relative distributions of charged and hydrophobic residues and their 
interaction interplays in bilayer interfaces, which is in clear contrast to intracellular antibiotics that use diferent 
pathways to cross bacterial membranes. Indeed, the acquired cross-resistance of S. typhimurium proved to be 
inefective against tetracycline and cetriaxone (Table 2).
Conclusion
he original CecB adopts a helix of imperfect amphipathicity with polar residues occupying the hydrophobic 
face and vice versa (Fig. 1a)14. he polar residues promote membrane binding, but also interfere with the 
insertion of hydrophobic residues into membranes and consequently inhibit interfacial structuring deep inside 
the bilayer25. Imperfect amphipathicity can be balanced by a neutral alanyl cluster separating two asymmetric 
cationic facets21. In ChoC the glycine zipper partitions hydrophobic and polar residues by embedding the 
hydrophobic face, which breaks helix cooperativity exactly at the polar-hydrophobic interface (Fig. 2a). his 
may be gradually stabilized in membranes, arranging nearly perfect amphipathicity characteristic of trans-
membrane helices21. Replacing the glycine zipper in ChoC with single hydrophobic and cationic residues result 
in a much faster migration dynamics, which monolayer poration can readily facilitate (Fig. 2)25. Equally, intro-
ducing multiple cationic and hydrophobic faces in CecB can enhance imperfect amphipathicity by allowing 
contiguous electrostatic and hydrophobic pairings that would support interfacial contacts in lipid bilayers 
as well as tight packing of monomeric helices into low-oligomer bundles (Fig. 1a)27. he bundles introduce 
three-dimensional equipotential surfaces with limited freedom for translational and rotational motion thereby 
settling for a restricted mode of poration46. As anticipated, CecM assembled into compact, small and shallow 
pores agreeing with a conserved mechanism engaged in the outer lealet of the bilayer (Figs 2b and S3). ChoM 
instead exhibited persistent intercalation dynamics accompanied by the cooperative and fast removal of mon-
olayer phospholipids in minutes (Figs 2b and S3). Given that all four of these peptides were strongly antimicro-
bial and non-hemolytic (Table 1) and that their biological activities correlated with their preferential folding in 
AUVs, and not in ZUVs (Fig. S1), the study permits a collective conclusion that HDP sequences allow for the 
tuneable disruption of microbial phospholipid bilayers.
Emerging bacterial strains also develop diferent molecular strategies: to alter cell surfaces and endow them 
with cross-resistance toward membrane-active antibiotics. Now classical approaches include Gram-positive 
methods of neutralising cell walls by modifying teichoic acids with D-alanine61 and more recently discovered 
tools of Gram-negative pathogens to fortify LPS with phosphoethanolamine conjugated to phosphate groups62 or 
via the glycylation of aliphatic acyl chains63. All such modiications, however subtle, confer resistance to HDPs. 
Conversely, antimicrobial sequences themselves present cryptic, but practical, strategies for circumventing evolv-
ing resistance mechanisms64. As it was long proposed7, developing a widespread resistance against HDPs, which 
are evolutionarily conserved molecules, would carry a high cost. Although resistance mechanisms against HDPs 
do emerge, these are not universally applied across even one family and are readily counteracted by seemingly 
marginal alternations in peptide structure. As demonstrated here, it is the intrinsic property of an HDP to express 
amenable membrane-disruption mechanisms, which can be tuned using simple mutations. We ind this property 
remarkable as it indicated and exploits a phenomenal structural plasticity of the peptides with respect to their 
function: irrespective of their exact origin, sequences and modes of action, HDPs continue to target microbial 
membranes in one way or another. A critical question that never ceases to amaze is why both natural and engi-
neered HDPs occur in such numbers and diversity.
To a large extent, this could be explained by that HDPs exhibit multiple mechanisms of action including intra-
cellular targeting and binding to cell-surface receptors. Similarly, microbial resistance mechanisms are not limited 
to cell surface or membrane modiications and may involve elux pumps that block the passage of HDPs into the 
cell or the secretion of peptide efectors that block access to cell membranes65,66. herefore, the host-pathogen 
arms race is also likely to involve multiple and simultaneous adaptions in bacteria that may be matched or coun-
teracted by those in evolving HDPs.
his work provides at least a partial and complementary answer. Namely, each archetypal HDP remains a 
well optimised structural template that combines a repertoire of diferent mechanisms, the best of which can be 
selected to execute efective antimicrobial responses. Consequently, these designs can ofer the discovery of dis-
tinct antimicrobial mechanisms that can benchmark inter-relationships between poration and carpet-like mech-
anisms encoded by a given HDP.
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Methods
ƤǤ All peptides were assembled on a Liberty-1 microwave peptide 
synthesizer (CEM Corp.) as peptide amides using solid phase Fmoc/tBu protocols, HBTU/DIPEA as coupling 
reagents and Rink amide 4-methylbenzhydrylamine resin (Novabiochem, UK). Fmoc-Ala-OH-3, 3, 3-d3 (Sigma 
Aldrich) was used for the synthesis of GALA d3-peptides. Following post-synthesis work-up and puriication 
the identities of the peptides were confirmed by analytical RP-HPLC and MALDI-ToF mass spectrometry. 
MS [M + H]+: CecB, m/z 3834.6 (calc), 3836.0 (found); CecM, m/z 3968.1 (calc), 3969.1 (found); ChoC, m/z 
2572.2 (calc), 2573.5 (found); ChoM, m/z 2699.4 (calc), 2703.3 (found); V4Ad3-ChoM, m/z 2674.4 (calc), 2675.4 
(found); I8Ad3-ChoM, m/z 2660.3 (calc), 2664.5 (found); I12Ad3-ChoM, m/z 2660.3 (calc), 2665.1 (found); 
V20Ad3-ChoM, m/z 2674.4 (calc), 2678.1 (found).
Ǥ Analytical and semi-preparative gradient RP-HPLC was 
performed on a JASCO HPLC system using Vydac C18 analytical (5 µm) and semi-preparative (5 µm) columns. 
Both analytical and semi-preparative runs used a 10− 60% B gradient over 50 min at 1 mL/min and 4.7 mL/min 
respectively with detection at 230 and 220 nm. Bufer A – 5% (vol/vol) and bufer B – 95% (vol/vol) aqueous 
CH3CN, 0.1% TFA.
Ǥ Minimum inhibitory concentrations (MICs) were deter-
mined by broth microdilution on P. aeruginosa (ATCC27853), E. coli (K12), S. aureus (ATCC6538), M. luteus 
(NCIMB13267), B. subtilis (ATCC6633), S. typhimurium (DA6192) and E. faecalis (OG1X) according to the 
Clinical and Laboratory Standards Institute and as recommended for antimicrobial peptide testing67. Typically, 
100 µL of 0.5–1 × 106 CFU per ml of each bacterium in Mueller Hinton media broth (Oxoid) were incubated in 
96-well polystyrene microtiter plates with 100 µL of serial twofold dilutions of the peptides (from 100 to 0 µM) at 
37 °C on a 3D orbital shaker. he absorbance was measured ater peptide addition at 600 nm using a Victor 2 plate 
reader (Perkin-Elmer). MICs were deined as the lowest peptide concentration ater 24 h at 37 °C. All tests were 
done in triplicate and results are summarised in Table 1. he mutant strains of S. typhimurium, named using the 
original nomenclature, were kindly provided by Dan Andersson55. All tests for the mutants were done in triplicate 
and results are summarised in Table 2.
Ǥ Hemolysis was determined by incubating a 10% (vol/vol) suspension of human eryth-
rocytes with peptides. Erythrocytes were rinsed four times in 10 mM phosphate bufer saline (PBS), pH 7.2, by 
repeated centrifugation and re-suspension (3 min at 3000 × g). Erythrocytes were incubated at room temperature 
for 1 h in either deionized water (fully haemolysed control), PBS, or with peptide in PBS. Ater centrifugation at 
10,000 × g for 5 min, the supernatant was separated from the pellet, and the absorbance was measured at 550 nm. 
Absorbance of the suspension treated with deionized water deined complete hemolysis. he values given in 
Table 1 correspond to concentrations needed to kill a half of the sample population (50% lysis of human erythro-
cytes) and are expressed as median lethal concentrations—LC50. All tests were done in triplicate.
ǦǤ E. coli and B. subtilis cells were centrifuged to give a cell pellet, which 
was washed twice with 10 mM phosphate bufer (pH 7.4) before being reconstituted in phosphate bufer. 100 µl of 
the solution was dispensed in an 8-well chamber (LabTek) with diluted (1/500) propidium iodide (PI) (1 mg/mL, 
Invitrogen). he chambers with surface settled bacteria was mounted on a confocal microscope (IX 81, Olympus) 
equipped with 37 °C. PI luorescence emission was monitored at 625 nm for 60 minutes ater the addition of 
the peptide to a inal concentration of 10 µM. Recorded images were analysed using ImageJ sotware to plot the 
number of luorescent (stain-dead) cells as a function of time. he values are expressed as a percentage of the total 
number of cells (taken as 100% for each point).
Ȁ®™Ǥ E. coli and B. subtilis cells were centrifuged to 
give a cell pellet, which was washed twice with 10 mM phosphate bufer (pH 7.4) before being reconstituted 
in the same bufer to give OD600 nm = 0.01. A 100-µL aliquot of the solution was dispensed in an eight-well 
glass chamber (LabTek) with LIVE/DEAD® BacLight™ bacterial viability kit (Invitrogen). he chambers with 
surface-settled bacteria (20 min) were mounted on a confocal microscope (Olympus) equipped with an incuba-
tion chamber at 37 °C. SYTO®9 and PI luorescence emission was monitored at 515 nm and 625 nm, respectively, 
at diferent time points for 45 min ater the addition of peptides. Recorded images (XY) were analyzed using 
ImageJ sotware.
Ǥ 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC) 
with 1,2-dilauroyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DLPG) and (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) with 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) 
(POPG)) lipids used for vesicle construction were from Avanti Polar Lipids (Alabaster, USA). DLPC and POPC 
were used as mammalian model membranes, and DLPC/DLPG (3:1, molar ratios) and POPC/POPG (3:1, molar 
ratios) were used as bacterial model membranes. he lipids were weighted up, dissolved in chloroform-methanol 
(2:1, vol/vol), dried under a nitrogen stream and then under vacuum to form a thin ilm. he ilm was hydrated 
in 10 mM phosphate bufer (pH 7.2) with shaking (1 h, 220 rpm) and bath sonicated. he obtained suspension 
was extruded using a hand-held extruder (Avanti Polar lipids) (twenty times, polycarbonate ilter, 0.05 µm) to 
give a clear solution containing small unilamellar vesicles, which were analysed (50 nm) by photon correlation 
spectroscopy. he lipid ilms were hydrated in 10 mM phosphate bufer prepared with deuterium depleted water 
for NMR experiments and in 20 mM HEPES bufer for AFM experiments.
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Ǥ Vesicles were re-suspended to a inal concentration of 1 mg/mL and 
were analysed on a Zetasizer Nano (ZEN3600; Malvern Instruments). Dynamic light scattering batch measure-
ments were carried out in a low volume disposable cuvette at 25 °C. Hydrodynamic radii were obtained through 
the itting of autocorrelation data using the manufacturer’s sotware, Dispersion Technology Sotware (DTS ver-
sion 5.10).
Ǥ All CD spectra were recorded on a JASCO J-810 spectropolarimeter 
itted with a Peltier temperature controller. All measurements were taken in ellipticities in mdeg and converted 
to molar ellipticities ([θ], deg cm2·dmol−1 res−1) by normalizing for the concentration of peptide bonds. Aqueous 
peptide solutions (300 µL, 30 µM) were prepared in iltered (0.22 µm), 10 mM phosphate bufer, pH 7.4. CD spec-
tra recorded in the presence of synthetic membranes are for lipid-peptide (L/P) molar ratios of 100.
	Ǥ Supported lipid bilayers were formed on 
mica as described elsewhere25 from a vesicle solution of 4 mg/ml DLPC/DLPG (3:1, molar ratio). he vesicle solu-
tion was incubated at a inal concentration of 75 µg/mL on a freshly cleaved mica disk (Agar Scientiic, UK) for 
60 minutes in 150 mM NaCl, 20 mM HEPES pH 7.2, with 20 mM MgCl2 and 20 mM CaCl2. Ater absorption, the 
solution was washed ive times with bufer, to remove unfused vesicles from solution. Peptides were introduced 
into the 100-µl luid cell (Bruker AXS, USA) and diluted in the existing bufer solution (150 mM NaCl, 20 mM 
HEPES pH 7.2) to the inal concentration stated.
Ǥ Topographic images of supported lipid bilayers in 20 mM HEPES con-
taining 150 mM NaCl, 20 mM MgCl2 and 20 mM CaCl2 (pH 7.2) were recorded on a Multimode 8 AFM (Bruker 
AXS, USA) operated in PeakForce Tapping mode at PeakForce frequency 2 kHz, PeakForce amplitude 10 nm, 
set-point 20–40 mV (<100 pN). Images were recorder at 512-512 pixels at line rates of 1–2 Hz. he AFM probes 
were MSNL-E and MSNL-F (0.1, 0.6 N/m) (Bruker AFM probes, USA). Images were processed using NanoScope 
Analysis (Bruker AXS, USA) for 0th order line-by-line background subtraction (lattening) to remove ofsets 
between scan lines and irst-order plane itting to remove sample tilt in the Nanoscope Analysis sotware (Bruker 
AXS, USA). Cross-section measurements were carried out using NanoScope Analysis or Gwyddion (http://gwy-
ddion.net/) and plotted using Origin (OriginLab, USA).
Ǥ All simulations were performed using a model phospholipid bilayer 
of the same lipid composition used in the experiments (DLPC/DLPG, 3:1 molar ratio). Peptide-membrane sys-
tems were parameterised using the CHARMM36 force ield for lipids, CHARMM27 for peptides, and TIP3P for 
water. Sodium counter ions were used for charge neutralization. All four peptide amides were modelled as ideal 
helices using three initial conigurations: (a) transmembrane, perpendicular to the surface of the phospholipid 
bilayer; (b) parallel to the bilayer at the upper lipid-water interface; (c) embedded in the upper lealet of the bilayer 
and tilted by 20 degrees. In each coniguration, simulations were for 10–16 monomeric helices at L/P ratios of 
20–200. he peptides were built as α-helices using PyMOL 1.8 (Schrödinger, LLC). Each helix was placed on a 
grid with the desired orientation using VMD and combined with membranes of two diferent sizes, followed by 
equilibration68. he membranes of 12 × 12 nm were used for lower ratios (up to 55) and 20 × 20 nm for higher 
ratios (≥55). In total, 20 peptide-membrane systems for ~200 peptides were equilibrated, run and analysed: all 
four sequences in two membrane types in three conigurations for smaller and in two conigurations for larger 
membranes. All peptide-membrane systems were equilibrated using the following protocol: (a) 5000 minimiza-
tion steps; (b) 10 ns with harmonic constraints (1 kcal/mol/A2) on peptides and lipid head groups; (c) 10 ns with 
harmonic constraints (1 kcal/mol/A2) on peptides only, and the membrane area allowed to change; (d) 10 ns 
without constraints, with the membrane area allowed to change. Production runs were 500 ns each with constant 
temperature, pressure and membrane area maintained by a Langevin thermostat and a Nosé-Hoover Langevin 
piston barostat. All the simulations were carried out with the NAMD 2.9 sotware68. Analyses were performed 
and igures prepared using VMD69.
he improved amphipathicity of CecM compared to CecB was evaluated by calculating the mean hydrophobic 
moment using HeliQuest70. he mean hydrophobic moment is a two-dimensional vector sum which provides a 
direct, quantitative measure of amphipathicity in regular repeats71. he mean hydrophobic moment increases 
from CecB (0.296) to CecM (0.350). For comparison, values for PGLa and magainin, two naturally occurring 
HDPs, are 0.260 and 0.286, respectively72. Percentage of secondary structure elements was calculated using 
STRIDE73. Oligomerisation simulations were performed over 500 ns for the four peptides in all three starting 
conigurations. Loose associations are mainly represented in the plots (distance cut of used was 6 Å between any 
pair of heavy atoms belonging to diferent peptides). Local conformational changes in ChoM and ChoC due to 
the replacement of two glycyl residues in ChoC were calculated using Bendix74.
ǦǢ
Ǥ Each deuterated peptide was dissolved together with POPC/POPG (3:1, molar ratio) 
in chloroform:methanol:water (45:45:10) at the required molar ratio. Lipids at 3 mg/cm2 were applied to ultrathin 
microscope cover glass slides with dimensions 5.7 × 11 mm (Paul Marienfeld GmbH & Co KG, Germany). he 
peptide lipid mixture was air-dried at room temperature for 1 h and followed by additional drying in vacuum 
for 12 h. he lipid ilms were rehydrated at 96% relative humidity for 8 h at 37 °C, the slides were stacked on 
top of each other and hydrated for an additional 24 hours. he sample was inserted into a glass sample cell and 
sealed using bee wax. Lipid orientation was determined using 31P NMR with 1H decoupling on a 400 MHz Bruker 
Avance wide bore spectrometer using a double resonance probe, which was modiied with home built lattened 
coil (Fig. S16).
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he NMR experiments were performed on a 800 MHz Ininity plus wide pore spectrometer (Magnex, Varian). 
A low-e HX probe equipped with a lat-coil for static experiments was used75. NMR measurements were per-
formed at 20 °C using a quadrupole echo pulse sequence. A typical 2H NMR experiment would be performed at 
deuterium frequency of 122.78 MHz and an spectral width of 100 kHz using a 90° pulse length of 4 µs an inter-
pulse delay of 35 µs, followed by 60 µs pulse delay and a 0.5 s recycling delay. Between 500k and 700k scans were 
acquired per sample. he FID was let-shited to the echo maximum and line broadening was applied. Spectra 
recorded at a spectral width of 250 kHz were let shited by 10 data points and line broadened applying an expo-
nential window of 400 Hz; spectra recorded with a spectral width of 100 kHz were let shited by 8 data points and 
line broadened applying an exponential window of 200 Hz. he FIDs were processed using nmrPipe76.
 ?Ǥ ChoM at the required molar 
ratio was co-dissolved in chloroform-methanol-water (45:45:10; v/v) with corresponding lipid mixtures (POPC/
POPG (3:1; molar ratio), in each of which one lipid type was perdeuterated, i.e. POPC-d31 or POPG-d31. Each 
mixture was equally distributed across microscope cover slides (5.7 × 11 mm (Paul Marienfeld GmbH & Co KG, 
Germany)) at an overall lipid concentration of ≥3 mg/cm2 and 15 µL per slide. he slides were air-dried for one 
hour and then under vacuum for 18 hours. he ilms were rehydrated in a controlled environment for 96% humid-
ity for 8 hours at 37 °C. he slides were then stacked and subject to additional hydration (96% humidity, 37 °C) 
for 24 hours. NMR spectra were recorded on a 800 MHz Ininity plus wide bore using the same low-e HX probe 
as described above. he experimental error was estimated from the half line widths of the well-resolved central 
resonances of spectra corresponding to POPC-d31 and POPG-d31 in presence and absence of ChoM. Individual 
measured line widths are given in Table S3 together with an estimated experimental error77. he reported line 
widths are the average of the –vQ and the + vQ of the respective labelled acyl segment. he plotted error bars 
(Fig. S11) are in relation to this estimate and are scaled by a factor of two, as the Sseg is a diference measure of two 
individual resonances each with a separate experimental error.
Ǥ Pake doublets were assigned for the 
resolved centre region of the more dynamic segments (typically 6–7 quadrupolar splittings could be assigned). 
Monochromatic decay was assumed for the overlapping doublets in the outer wing regions corresponding to the 
segments located close to the headgroup78. he assigned quadrupolar splittings were related to segmental order 
parameters as described by:
∆ = ⋅
e qQ
h
S3/4
(1)vq CD
2
where e qQ
h
2
 is the quadrupolar coupling constant and the segmental order parameter (SCD) is given by:
θ= ⋅ −S cos1/2 (3 1) (2)CD CD
2
where θCD corresponds to the angular constraint of the C-D bond vector.
he net bilayer thinning due to changes in the order proile were estimated based on:
∆ ∆=d L S2 (3)0
where L0 is the length of the all trans –acyl chain (taken to be 26–27 Å for PO lipids)79 and ∆〈|S|〉 is the average 
change of the lipid order across the bilayer. Note that this can only be seen as an approximation of the mean 
change in bilayer thickness and localized efects might be plausible.

ȋ
ȌǤ Distinct quadrupolar splittings resolved for each of 
the selectively deuterated positions were simulated based on the Cα−Cβ bond vector within the peptide sequence. 
Simulation parameters are in accordance with NMR parameters: a B1 ield of 18.8 Tesla, sweep width of 100 kHz 
and a total of 1024 points. he simulated FID was zero illed by 1024 points and the apodization of 80 Hz was 
applied before Fourier Transformation. he real part of the spectrum was plotted. A straight alpha helix was 
assumed that was described by three Euler angles assuming a side chain tilt of 55.2° ([0.0; 55.2; 0.0]), and the rota-
tional axis was centred to residue F5. A maximum quadrupolar splitting for deuterated methyl groups of 84 kHz 
was assumed and a structural order parameter of 0.76. Due to the sign ambiguity the absolute value of the quad-
rupolar splitting was used for itting and a total of 70 data points (0 to 180°) were simulated for tilt and rotational 
pitch resulting in a total of 19,600 simulated spectra for analysis. Published protocols were followed to ensure 
reproducibility in sample hydration80. Hydration to 96% of relative humidity at 37 °C was achieved in a controlled 
environment of supersaturated salt solutions containing a hydration chamber. Clear oriented lipid bilayers were 
obtained, with every oriented sample checked for good lipid alignment by 31P NMR prior to 2H NMR analysis 
(Fig. S16). he experiments were performed using low-e probes in order to minimise sample heating and dehy-
dration during the long experiment times. he sample weight before and ater each experiment was controlled to 
exclude possible dehydration. RMSD analysis was performed in accordance to81:
=
∑ −
RMSD
data expected
n
(( ) ( ))
(4)
2
he best it of 4.9 kHz was achieved for all four spectra for the inner components and of 3.8 kHz for the outer 
components. Gala-derived helix model was built using MODELLER82.
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